# Nuvation Bio Inc.: Form 8-K, filed May 17, 2022

- Company: [Nuvation Bio Inc.](/companies/nuvb.md) (CIK 1811063)
- Form: 8-K
- Filed: 2022-05-17
- Accepted by EDGAR: May 17, 2022, 16:36 ET
- Period: 2022-05-16
- Accession: 0001193125-22-153069
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1811063/000119312522153069/d468031d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1811063/000119312522153069/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1811063/000119312522153069/d468031d8k.htm

Filed May 17, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-153069. Last ingested by Listed: Nov 4, 2026, 17:21 ET. No prices; not investment advice.
